Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OCUP

Ocuphire Pharma (OCUP) Stock Price, News & Analysis

Ocuphire Pharma logo

About Ocuphire Pharma Stock (NASDAQ:OCUP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.17
$1.46
52-Week Range
N/A
Volume
676,700 shs
Average Volume
171,840 shs
Market Capitalization
$30.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Buy

Company Overview

Receive OCUP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ocuphire Pharma and its competitors with MarketBeat's FREE daily newsletter.

OCUP Stock News Headlines

Shareholder group nominates slate of director candidates for Opus Genetics
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Opus Genetics reinstated with a Buy at H.C. Wainwright
Ocuphire Pharma, Inc. Announces Acquisition of Opus Genetics
See More Headlines

OCUP Stock Analysis - Frequently Asked Questions

Ocuphire Pharma, Inc. (NASDAQ:OCUP) announced its quarterly earnings data on Friday, August, 11th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.23) by $0.01. The company had revenue of $3.67 million for the quarter. Ocuphire Pharma had a negative net margin of 85.75% and a negative trailing twelve-month return on equity of 30.19%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ocuphire Pharma investors own include NVIDIA (NVDA), Meta Platforms (META), Arista Networks (ANET), Broadcom (AVGO), ServiceNow (NOW), Novo Nordisk A/S (NVO) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
8/11/2023
Today
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OCUP
CIK
1228627
Employees
14
Year Founded
N/A

Price Target and Rating

High Price Target
$18.00
Low Price Target
$10.00
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.49)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.99 million
Net Margins
-85.75%
Pretax Margin
-85.68%
Return on Equity
-30.19%
Return on Assets
-27.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.68
Quick Ratio
10.68

Sales & Book Value

Annual Sales
$16.45 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.20 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
25,924,000
Free Float
24,469,000
Market Cap
$30.33 million
Optionable
Optionable
Beta
0.20

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:OCUP) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners